Mictonorm (Propiverine Hydrochloride)

Propiverine blocks muscarinic M3 receptors in the bladder detrusor muscle, reducing acetylcholine‑driven contractions. This antimuscarinic action, together with possible calcium‑channel blockade, lowers involuntary bladder activity and improves storage symptoms.

The appropriate dose of Mictonorm is determined by the prescribing physician based on the individual patient's condition, age, renal and hepatic function, and response to therapy. Dosage regimens are individualized and should follow the prescriber's instructions.

Safety data for propiverine hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To order Mictonorm, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mictonorm (propiverine) offers antimuscarinic activity similar to other agents such as oxybutynin or tolterodine, but it may provide additional calcium‑channel blocking effects that can enhance bladder relaxation. Choice of therapy depends on efficacy, tolerability, patient comorbidities and physician preference.

Mictonorm should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, heat and direct sunlight to maintain stability and potency.

Mictonorm is taken orally. The tablet should be swallowed whole with a glass of water, preferably at the same time each day, unless otherwise directed by the prescribing clinician.

Serious risks include acute urinary retention, severe constipation that may lead to bowel obstruction, allergic reactions such as rash or angioedema, tachycardia, liver enzyme abnormalities, and QT‑interval prolongation, which can predispose to cardiac arrhythmias.

Mictonorm is contraindicated in patients with known urinary retention, severe uncontrolled narrow‑angle glaucoma, or hypersensitivity to propiverine or any excipients. Caution is advised for individuals with significant hepatic or renal impairment, the elderly, and those taking other strong anticholinergic drugs.